These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril. Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364 [TBL] [Abstract][Full Text] [Related]
24. Isosorbidedinitrate and SIN-1 as dilators of human coronary arteries and platelet inhibitors. Bult H; Bosmans JM; Vrints CJ; Herman AG J Cardiovasc Pharmacol; 1995 Apr; 25(4):572-8. PubMed ID: 7596125 [TBL] [Abstract][Full Text] [Related]
25. [Anti-ischemic effects of SIN-1, a molsidomine metabolite, during coronary angioplasty and antiplatelet effects in humans]. Darius H; Erbel E; Schmucker B; Reusch U; Meyer J Presse Med; 1988 May; 17(20):1033-6. PubMed ID: 2969099 [TBL] [Abstract][Full Text] [Related]
26. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries. Takeuchi M; Nohtomi Y; Kuroiwa A Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310 [TBL] [Abstract][Full Text] [Related]
27. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. Fugit MD; Rubal BJ; Donovan DJ J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269 [TBL] [Abstract][Full Text] [Related]
28. Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium. Yousif MH; Yousif F; Thulesius O Cardiovasc Drugs Ther; 1991 Aug; 5(4):769-73. PubMed ID: 1909561 [TBL] [Abstract][Full Text] [Related]
34. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation. Basista M; Grodzińska L; Swies J Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480 [TBL] [Abstract][Full Text] [Related]
35. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. Holtz J; Giesler M; Bassenge E Z Kardiol; 1983; 72 Suppl 3():98-106. PubMed ID: 6666237 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the influence of nitrates, molsidomine and SIN-1, a molsidomine metabolite in acute coronary insufficiency. Degré S; Sobolski J; Berkenboom G; Abramowicz M; Vandermoten P; Stoupel E Bibl Cardiol; 1985; (39):129-34. PubMed ID: 3842256 [No Abstract] [Full Text] [Related]
37. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151 [TBL] [Abstract][Full Text] [Related]
38. [Hemodynamic effect of molsidomine in acute administration and as a long-term medication]. Osterspey A; Jansen W; Tauchert M; Schell U; Fuchs M; Hombach V; Hilger HH Med Welt; 1983 Apr; 34(17):523-8. PubMed ID: 6408341 [No Abstract] [Full Text] [Related]
39. The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog. Schini VB; Bond R; Gao Y; Illiano S; Junquero DC; Mombouli JV; Nagao T; Smart F; Vanhoutte PM J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S10-6. PubMed ID: 7504762 [TBL] [Abstract][Full Text] [Related]
40. Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries. Tousoulis D; Davies GJ; Tentolouris C; Crake T; Goumas G; Stefanadis C; Toutouzas P Heart; 2003 May; 89(5):531-4. PubMed ID: 12695458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]